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1. Introduction
  Albendazole and mebendazole is known to be efficacious 
for the treatment of Ascaris lumbricoides (A. lumbricoides)[1].
In spite of its high efficacy, there were concerns of the 
emergence of drug resistance with these agents in human 
and animals from Africa and Southern America[1-3]. So 
far, there is no report of drug resistance of albendazole or 
mebendazole for the treatment of A. lumbricoides from Asia. 
In spite of the lack of reported drug resistance, this issue in 
Asia remains unclear. An investigation to find out whether 
drug resistance exists in this region is therefore essential. 
Demographic similarities that all the regions share such as 
the tropical climate, lower standards of hygiene and nutrition 
should alert physicians in Asia for the possibility of drug 
resistance. This aspect is thus important as A. lumbricoides 
mostly affects school-age children. North-Western 
Indonesia where the island of Sumatera lies is very close to 
the main continent of Asia was chosen as a good target area 
to perform this study.
  Therefore, this study was done to investigate if drug 
resistance towards albendazole and mebendazole for the 
treatment of A. lumbricoides is present in this region. The 
project was not only designed to study the drug efficacy in 
relation to the possible drug resistance but also to  further 
study the drug effectiveness in sterilizing A. lumbricoides eggs. 
Both drug efficacy and drug effectiveness are important 
factors in relation to the prevention and eradication of the 
helminth.
Objective: To investigate the efficacy and effectiveness of albendazole and mebendazole in the 
treatment of Ascaris lumbricoides (A. lumbricoides) in the North-Western Indonesia. Methods: 
229 primary school children who were positive for A. lumbricoides in their stool were recruited 
in the study. 123 children received single-dose of 400 mg albendazole and 106 children received 
single-dose 500 mg of mebendazole. After 1 week, their stools were examined for the cure rate 
(CR) and egg reduction rate (ERR). Egg culture was also performed and observation was made 
on week-1, -3, -4. Results: have shown a non-significant difference in CR 96.7% vs. 100%; and 
ERR of 99.3% vs. 100.0% for albendazole and mebendazole groups respectively (P>0.05). In-vitro 
egg culture has shown trends of decrease in the percentage of the unfertilized eggs and in ≥ 2 
cell eggs in both treatment groups (P<0.05). The embryonated eggs from the albendazole groups 
has shown an increase from 7.3% on week-1 to 13.8% on week-4, whilst the mebendazole group 
has shown a constant increase during the whole 4 weeks of culture from 7.5% to 28.3% (P<0.01). 
Conclusions: No evidence of drug resistance is noted so far from the area of North-Western part 
of Indonesia. In addition, although both drugs showed incomplete ovicidal effects, single-dose 
albendazole is better than mebendazole in sterilizing A. lumbricoides eggs.
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2. Materials and methods
  The study was performed among primary school children 
in two districts within the province of North Sumatera, 
Indonesia. This area is located in the North-western part of 
Indonesia. The study areas are district of South Aek Nabara-
Labuhan Batu and district of Kabanjahe-Tanah Karo. The 
choice of the two districts is made based on the previous 
survey that was reported by the department of health as 
the most endemic districts for A. lumbricoides infection 
in the province. The study has received ethical committee 
clearance from the School of Medicine of the University of 
North-Sumatera and the informed-consents have been given 
from the parents and the school principals. 
  Preparation day: The day when primary school children 
gave their stool samples. Stools were collected as early 
morning stool, or afternoon stool taken at home if the 
children could not pass motion in the morning. All stool 
samples were examined using Kato-Katz method[4]. 
Samples that were infected by single infections of 
Trichruris trichiura, hookworm or Enterobius vermicularis 
were excluded, and only stools with single infection of
A. lumbricoides or mixed infections of A. lumbricoides with 
other soil-transmitted helminthes were selected. Two-
hundred-twenty-nine children that were positive for
A. lumbricoides were finally selected. The egg number from 
each stool sample was counted which is to be used as the 
baseline data for the cure rate and for egg reduction rate 
(ERR) and also to sub-classify the stool samples based on 
the number of eggs per gram feces (epg). The epg count is 
to be used to categorize the infection as mild (epg < 5 000), 
moderate (epg 5 000-49 999) and severe (epg > 50 000)[5]. 
  Day-0: all infected children were randomly assigned using 
random-number table into two groups to receive either 
single dose of 400 mg of albendazole or single dose of 500 mg
of mebendazole.
  Day-1: is the day following the medication where stool 
samples were cultured to see the development of egg 
maturation. 
  Week-1: there were two tasks done on week-1: 
  (1) Counting of the egg number for calculation of the cure 
rate as well as for the ERR. The egg counting is done using 
fresh stool sample using Kato-Katz technique[6,7]; 
  (2) Observation and counting of the egg maturation stages 
taken from the egg culture. 
  The observation and egg maturation counting from the egg 
culture was also performed by week-3 and week-4. The egg 
maturation stages are grouped into egg with one cell, two or 
more cells, and embryonated egg. The result of each grouped 
is expressed as percentage of the total egg number. 
  “Stool culture procedure”; into a plastic jar that has been 
given level mark, the examiner transferred stool using a 
spatula up to that level. The stool was later immersed in 30 
mL of 2% potassium bichromate and left at room temperature 
(25-32 曟) for 4 weeks. They were all placed in clean room 
where the jars were not covered by lid and kept open. The 
observation of the egg maturation and counting of the stage 
were done on week-1, -3, -4.
  Observation of the egg maturation was not done by week-2. 
The reason that the observation was not done by week-2 
is because eggs during in-vitro embryonation at room 
temperature showed that molt takes within the egg after 17-
22 d. So we expect retardation in the egg development, and 
therefore we did not do the assessment of the culture by 
week-2. 
  Preparation of stool smear for differential egg counting was 
carried out using the same Kato-Katz technique as describe 
above. The egg maturation stages were grouped into: 
unsegmented eggs (1 cell); ≥ 2 cell eggs (1 cell + 2 cells; 
1 cell + 4 cell; 2 cells + 4 cells; 1 cell + 2 cells + 4 cells), 
and embryonated eggs. The result of each egg maturation 
stage was expressed in relative percentage of the total egg 
number. 
  Statistical analysis was carried out using Wilcoxon-rank-
sum test and Chi-square test to see the difference between 
anthelminthic and the intensity of A. lumbricoides infection. 
In order to see the tendency whether there is increase or 
decrease of every step of the egg maturation during weeks 
of maturation, statistical calculation is performed by one-
way analysis of variance (ANNOVA). The difference of the 
egg evolution between the two treatment groups is carried 
out using multivariate analysis of variance (MANOVA). All 
statistical tools come from SPSS version 14.0.
3. Results
  All stools from the school children were first investigated 
for A. lumbricoides by Kato Katz examination. 229 stool 
samples fulfilled the criteria and they were divided based 
on the worm burden (epg) into mild infection (epg < 5 000), 
moderate infection (epg 5 000-49 999) and severe infection 
(epg > 50 000). 189 samples fulfilled the criteria of mild 
infection, 38 samples of moderate infection and 2 samples of 
severe infection. They were later randomized into two groups 
to receive the treatment. 123 children received albendazole 
and 106 children received mebendazole, and were further 
analyzed based on the worm burden:
  The mild infection group showed that children who 
received albendazole were 105 out of 123 (85.4%) whilst 
mebendazole were 84 out of 106 (79.2%) (P>0.05). In the 
moderate infection group, 17 out of 123 (13.8%) who received 
albendazole showed no significant difference to 21 out of 
106 (19.9%) (P>0.05). The severe infection group showed that 
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1 out of 123 (0.8%) of the albendazole group and 1 out of 106 
(0.9%) of the mebendazole group had no statistical difference, 
(P>0.05). Based on the intensity of the infection as measured 
by the worm burden as a whole, both treatment groups 
showed no difference (P>0.05).
  The calculation of the cure rate (CR) and the ERR was 
done using fresh stool samples taken on the preparation day 
and on week-1, and showed that there was no significant 
difference in the intensity of A. lumbricoides infection 
between the albendazole and mebendazole. The CR of 
albendazole and mebendazole groups are 96.7% and 100.0% 
respectively, but statistically they do not show significant 
difference (P>0.05). The ERR of albendazole is 99.3% while 
the ERR of mebendazole is 100.0% (P>0.05).
  The stool cultures of the albendazole and mebendazole 
groups showed similar pattern. Both showed final increase 
in unsegmented eggs after 4 weeks of culture (P<0.05), and 
constant decrease pattern in ≥ 2 cell eggs (P<0.05). 
  The embryonated eggs showed different pattern between 
albendazole and mebendazole groups. In albendazole 
group, there was an increase of the embryonated eggs 
during week-3 but dropped again a week later (P<0.05). In 
mebendazole group there was a significant constant increase 
of the embryonated egg number from the beginning till 4 
weeks of culturing (P<0.05). 
  In order to see the evolution of egg maturation as a whole 
during 4 weeks of drug treatment, statistical analysis by 
multivariate analysis of variance was carried out and the 
result showed significant difference between albendazole 
and mebendazole (P <0.01). 
  For the embryonated eggs, both groups showed non-
significant increase during week-1 and week-3. 
Nonetheless, during week-4 the embryonated eggs 
were significantly lower in the stool of children who 
received albendazole compared to children who received 
mebendazole(Table 1&2) (P<0.01).
Table 1
Percentage of A. lumbricoides eggs during their maturation in the culture (week 1-4).
Week-1 (%) Week-3 (%) Week-4 (%) P
Abendazole Unsegmented 20.3 21.1 26.0 < 0.05
≥ 2 cell egg 15.4 10.6   9.8 < 0.05
Embryonated   7.3 19.5 13.8 < 0.05
Unfertilized egg 57.0 48.8 50.4 < 0.05
Mebendazole Unsegmented 21.7 19.8 25.5 < 0.05
≥ 2 cell egg 25.5 17.9 15.1 < 0.05
Embryonated   7.5 14.2 28.3 < 0.05
Unfertilized egg 45.3 58.1 31.1 < 0.05
Annova is used to analyze the trend of every step of the egg maturation during weeks of maturation.
       
Table 2
The overall egg maturationl effect of albendazole and mebendazole during 4 week of culture.
Week-1 (%) Week-3 (%) Week-4 (%) P
Abendazole 1 cell & 2 cells   8.9   4.9   4.1 < 0.01
1 cell & 4 cells   2.4   1.6   0.0 < 0.01
2 cells & 4 cells   0.0   0.0   0.0 < 0.01
1 cell, 2 cells, 4 cells   4.1   4.1   5.7 < 0.01
Mebendazole 1 cell & 2 cells 17.0   9.4   8.5 < 0.01
1 cell & 4 cells   1.9   1.9   0.9 < 0.01
2 cells & 4 cells   0.0   0.9   0.0 < 0.01
1 cell, 2 cells, 4 cells   6.6   5.7   5.7 < 0.01
Multivariate analysis of variance is used to analyze the egg maturation effect of albenadazole and mebendazole, and the overall result shows that 
there is overall trend difference on the egg maturation between the two treatment groups.
4. Discussion
  A. lumbricoides infection can usually be prevented by 
single dose of broad-spectrum anthelmintics such as 
albendazole or mebendazole given in low dose at prolonged 
intervals. School-age children are the most common to 
be affected by A. lumbricoides and administration of these 
drugs to school-age children can maintain worm burdens 
below pathogenic levels. Due to this fact, there is increased 
use of both drugs in many endemic areas which may lead to 
possible development of drug resistance. Recently, there is 
concern about emergence of drug resistance in human and 
animals from Africa[8], South-America[3,9] and Australia[10]. 
Although albendazole and mebendazole have been proven 
to be effective and safe, however issue of drug resistance 
should be put into special attention because anthelmintic 
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drug resistance is an irreversible problem. So far, reports 
about emergence of drug resistance to A. lumbricoides 
came only from some countries in Africa, South-America, 
Australia and no report on this issue came from Asia[11]. 
There was a report about low efficacy of these drugs in Asia 
but it was not to A. lumbricoides but to hookworm and other 
intestinal worm infections[12-13]. In spite of no report of 
drug resistance to A. lumbricoides from Asia, it is necessary 
to find out whether reduced efficacy of albendazole and 
mebendazole to A. lumbricoides has also occurred in 
Indonesia; a part of South-East-Asian countries. 
  The result of the CR+ of albendazole and mebendazole 
from our study proves that the CR of both drugs are higher 
than 95%, the level that is considered as efficacious against
A. lumbricoides infection[11]. CR is 96.7% for albendazole and 
100.0% for mebendazole but statistically they do not show 
significant difference. The ERR also showed good result 
which is 99.3% and 100% for albendazole and mebendazole 
respectively. This finding is similar with the previous report 
from that came from the close neighboring country. One 
recent study that was aimed not specifically to find out drug 
resistance has shown that in some countries in Asia the cure 
rates and the ERR are similar to our results[11]. This proves 
that reduced efficacy or drug resistance does not happen in 
this region.
  The other important issue that needs to be put into account 
is that current antihelminthics have only temporary effect. 
Treatment although given in correct dosage gives only 
transitory effect and re-infection may occur[14-16]. It is 
therefore important to assess not only the drug efficacy 
in terms of the CR and ERR, but also to see possible 
embryonation of the egg in-vitro by mean of culturing 
the egg. The embryonated egg is infective and when it 
contaminates the environment and later ingested by 
animal or human, the gastric juice will break down the egg 
shell and produce release of larva[17]. In this study, there 
is significant reduction in the percentage of unfertilized 
egg after 4 weeks of culuture. This may be caused by the 
ovicidal action of the albendazole and mebendazole or due 
to self-death of the unfertilized egg. On the other hand, 
the relative percentage of the unsegmented eggs in both 
groups increased. Nevertheless, as they are expression of 
the relative percentage, the increase might be due to the 
inversion result of the decrease of the unfertilized eggs.
  The result also shows that the embryonation of the egg was 
not abolished nor inhibited by both drugs. The appearance 
of the eggs containing 2 or more cells showed that the eggs 
reduced and developed into embryonated eggs. This shows 
that both albendazole and mebendazole do not abolish nor 
arrest the process of the embryonation. When we look at 
the pattern of the embryonated eggs; there is difference 
between between the albendazole and mebendazole groups. 
There is trend of embryonated eggs to increase after 3 weeks 
and dropped again after 4 weeks in the albendazole group. 
This decreasing number can happen because the eggs were 
being destroyed and there were less number of the eggs left 
to develop further into embryonated eggs. This may show 
that albendazole has ovicidal effect but its ovicidal action 
is delayed until 4 weeks after the treatment. On the other 
hand, the embryonated eggs in the mebendazole groups 
showed a constant increase during the 4 weeks of culture. 
This is an evidence that mebendazole does not inhibit 
the egg embryonation. Report from many studies shows 
similar result with our investigation that albendazole and 
mebendazole have incomplete ovicidal effects in human 
and in animal[18,19]. This result shows that in spite of good 
CR and ERR, the ovicidal effectiveness of the drugs is 
incomplete and is also potential to produce recurrence of 
the infection. Prolonged use, frequent recurrent infection 
and inappropriate dosage might lead to possible emergence 
of drug resistance. Discovery of new method of treatment is 
needed to anticipate this phenomenon either by discovery of 
single drug or combination of highly synergistic anthelmintic 
treatment[20-22]. 
  When the whole egg maturation stages including the 
embryonated eggs were analyzed with multi-variate analysis 
of variance, both groups showed a significant difference. This 
difference might be caused by difference in the maturation 
of the embryonated eggs and not in the earlier stage of the 
egg maturation. The increase in the number of unsegmented 
eggs, and the decrease in ≥ 2 cells eggs showed relatively 
similar pattern both in the albendazole and mebendazole 
groups. The difference comes in the number of the 
embryonated eggs during 4 weeks of culturing. The result of 
embryonated egg analysis confirmed this finding. There was 
similar increase of the embryonated egg on week-3 in both 
groups, but they showed different pattern later on week-4. 
Embryonated eggs of the albendazole group declined whilst 
the mebendazole group showed a constant increase (P<0.01).
  We conclude from our study that there is no evidence 
of drug resistance of both albendazole and mebendazole 
against A. lumbricoides in this region. In-spite of good CR 
and ERR, however the result from the in-vitro egg culture 
should be put into great account as single dose albendazole 
and mebendazole show incomplete ovicidal effects. The 
albendazole shows a better ovicidal effect but the effect 
appears only after 4 weeks of culture. Therefore, single 
dose albendazole has an important place in sterilizing 
A. lumbricoides eggs and in controlling environmental 
contamination.
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